0000899243-22-010332.txt : 20220309
0000899243-22-010332.hdr.sgml : 20220309
20220309202144
ACCESSION NUMBER: 0000899243-22-010332
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220307
FILED AS OF DATE: 20220309
DATE AS OF CHANGE: 20220309
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Werner Milton H.
CENTRAL INDEX KEY: 0001827621
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39676
FILM NUMBER: 22727085
MAIL ADDRESS:
STREET 1: 3350 RIVERWOOD PARKWAY SE, SUITE 1900
CITY: ATLANTA
STATE: GA
ZIP: 30339
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Inhibikase Therapeutics, Inc.
CENTRAL INDEX KEY: 0001750149
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3350 RIVERWOOD PARKWAY SE, SUITE 1900
CITY: ATLANTA
STATE: GA
ZIP: 30339
BUSINESS PHONE: 678-392-3419
MAIL ADDRESS:
STREET 1: 3350 RIVERWOOD PARKWAY SE, SUITE 1900
CITY: ATLANTA
STATE: GA
ZIP: 30339
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-03-07
0
0001750149
Inhibikase Therapeutics, Inc.
IKT
0001827621
Werner Milton H.
3350 RIVERWOOD PARKWAY SE, SUITE 1900
ATLANTA
GA
30339
1
1
1
0
President and CEO
Common Stock
5315433
D
Stock Option (right to buy)
1.07
2022-03-07
4
A
0
125000
0.00
A
2029-03-07
Common Stock
125000
125000
D
One-third of the options will vest and become exercisable on 3/7/2023, and the remaining portion will vest and become exercisable in 24 equal
monthly installments commencing on the first day of April 2024, subject to continued employment through each such
vesting date.
/s/ Milton H. Werner
2022-03-09